KU Leuven
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
KU Leuven
Jun 1, 2024, 10:26 |
Blog
Jef Verbeek: Open PhD-position Hepatology Research Unit Leuven!
Jef Verbeek, Assistant Professor of Medicine at KU Leuven, shared on LinkedIn: "Open PhD-position Hepatology…
May 23, 2024, 15:09 |
Insight
Abhishek D. Garg: Thrilled to share our lab's latest research on multiomics and spatial mapping of immunotherapy responses in kidney cancer patients
Abhishek D. Garg, Head of Laboratory of Cell Stress and Immunity (CSI) at KU Leuven,…
May 11, 2024, 01:27 |
Blog
Abhishek Garg: Circadian rhythm based regulation of CD8+T cell function dictates the efficacy of cancer immunotherapy
Abhishek Garg, Head of Laboratory of Cell Stress and Immunity (CSI) Lab at KU Leuven,…
Apr 8, 2024, 17:38 |
Blog
Abhishek Garg: Excellent commentary on our recent study on innovative dendritic cell vaccines and how to overcome unanticipated resistance
Abhishek Garg, Head of the Laboratory of Cell Stress and Immunity (CSI) at KU Leuven,…
Jan 23, 2024, 18:21 |
Insight
Our latest research on next-generation anti-cancer vaccines against T cell-depleted tumors - Cell Stress and Immunity Lab
Cell Stress and Immunity Lab shared on X/Twitter: "Thrilled to share our latest research on…
Jan 21, 2024, 07:28 |
Insight
Abhishek Garg: Innovative reverse translational approach helped us discover a novel dual-organ immuno-resistance pathway
Abhishek Garg, Head of the Laboratory of Cell Stress and Immunity (CSI) at KU Leuven,…
Nov 27, 2023, 17:03 |
Insight
Our latest work on deep single cell mapping of CD8+T cell in colorectal cancer patients leading to first Artificial Intelligence classification for Immunotherapy - Cell Stress and Immunity Lab
All:
7
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube